RecallDepth
Class II Terminated

GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.

This recall has been terminated (originally issued November 28, 2018).

Company
Sciegen Pharmaceuticals Inc
Recall Initiated
October 29, 2018
Posted
November 28, 2018
Recall Number
D-0271-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
18,760 HDPE bottles
Firm Location
Hauppauge, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Distribution

Nationwide

Lot / Code Info

60429-641-90 Irbesartan 150mg Tablets, 90 Count Bottle B161003 Sep-19 B161004 Sep-19 B161006 Sep-19 B161007 Sep-19 B161008 Nov-19 B161009 Nov-19 B161010 Nov-19 C161001 Feb-20 C161003 May-20 60429-641-30 Irbesartan 150mg Tablets, 30 Count Bottle GS019526 Nov-19 GS020252 Nov-19 GS020958 Nov-19

More recalls by Sciegen Pharmaceuticals Inc

View all recalls by this company →

Other recent Class II Drug recalls